ProPublica: “Five Drugs the FDA Doesn’t Want You to Know Relied on Tainted Data”
by Charles Seife and Rob Garver, Special to ProPublica
April 15, 2013
In 2011, the Food and Drug Administration determined that a major laboratory, the Houston facility of the now-defunct Cetero Research firm, had committed such “egregious” and pervasive research violations that years of its tests were potentially worthless. About 100 drugs were affected, but the FDA has declined to name them, saying to do so would reveal confidential commercial information. ProPublica was able to pinpoint five drugs whose approval rested, at least in part, upon data from the Cetero studies.